Jack Meehan
Stock Analyst at Barclays
(3.10)
# 1,050
Out of 4,818 analysts
134
Total ratings
70.73%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $260 → $240 | $220.25 | +8.97% | 14 | Apr 10, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $102.81 | +21.58% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $330.71 | -12.91% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $15.28 | +115.97% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $74.35 | +337.12% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $15.63 | +21.56% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $172.84 | -42.72% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $136.79 | +31.59% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $7.43 | +34.59% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $143.61 | +15.59% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $58.19 | -26.10% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $106.89 | +44.07% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $244.98 | +75.52% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $234.41 | +83.44% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $24.46 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $37.00 | +29.75% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,003.16 | -32.21% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $117.56 | -74.48% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $434.73 | -30.99% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.35 | +2,862.96% | 1 | Dec 11, 2017 |
Labcorp Holdings
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $260 → $240
Current: $220.25
Upside: +8.97%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $102.81
Upside: +21.58%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $330.71
Upside: -12.91%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $15.28
Upside: +115.97%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $74.35
Upside: +337.12%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $15.63
Upside: +21.56%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $172.84
Upside: -42.72%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $136.79
Upside: +31.59%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $7.43
Upside: +34.59%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $143.61
Upside: +15.59%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $58.19
Upside: -26.10%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $106.89
Upside: +44.07%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $244.98
Upside: +75.52%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $234.41
Upside: +83.44%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $24.46
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $37.00
Upside: +29.75%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,003.16
Upside: -32.21%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $117.56
Upside: -74.48%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $434.73
Upside: -30.99%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.35
Upside: +2,862.96%